Articles by Eric S. Langer - BioPharm International



Articles by Eric S. Langer

On the Horizon: New Expression Systems to Become Common Industry Platforms

New expression systems compete for attention.
Jun 1, 2009

New expression systems compete for attention.

Expression System Royalties Battle

With all of the new expressions systems being developed, companies must decide what improved production and yield are really worth.
Apr 1, 2009

With all of the new expressions systems being developed, companies must decide what improved production and yield are really worth.

New Expression Systems Create Opportunities for Innovators, CMOs, and Product Developers

But will concerns about regulatory issues, royalties, and return on past investments continue to impede industry adoption?
Mar 1, 2009

What will it take for the industry to embrace new hosts?

Indian Biopharmaceutical Industry: 2008 in Review

Production capacity continued to grow in India, but the country needs to improve its manufacturing compliance standards.
Dec 1, 2008

A closer look at the past year's development in India.

Contract Manufacturing in India: Is the CMO Model a Viable Business?

Indian biologics manufacturers can tap into the global biologics market by enhancing their quality image and maintaining cost competitiveness.
Nov 1, 2008

If Indian biologics manufacturers can establish a track record for recombinant products, enhance quality image, maintain cost competitiveness, and demonstrate technology transfer and regulatory knowhow, they are likely to be in the middle of the next boom in biologics manufacturing.

Pharmaceutical Distribution in India

Drug manufacturers in India are struggling to improve a highly fragmented domestic distribution network.
Oct 1, 2008

The rapid growth of the pharmaceutical industry in India is yet to create significant changes in the Indian distribution system.

The Visible Hand: Government Supports the Biopharmaceutical Industry

The Indian government is providing several incentives for local biopharmaceutical companies to grow and compete globally.
Aug 1, 2008

What the Indian government is doing to make its biotech sector as strong as its IT sector.

India's Bioinformatics Industry: An Engine for Global Growth

Experience and expertise is fueling opportunity.
Jul 1, 2008

The bioinformatics industry is currently one of the fastest growing fields in India's biotechnology sector. Indian IT companies have several advantages in the bioinformation field and can continue to grow their opportunities worldwide.

India's Clinical Trials Market Accelerates

There has been a perceptible change from skepticism to acceptance in how India is viewed for clinical trials.
May 1, 2008

Most local and global clinical research organizations (CROs) consider an operational presence in India as key to their overall business plans. India is clearly on course to become the next hub for clinical trials.



Click here